AMD Stock Rises on Bernstein Raise and AI Demand

AMD stock rose after Bernstein raised its 12-month target as record EPYC and MI300 data-center demand boosted flows ahead of May 5 Q1 2026 earnings.

April 16, 2026·2 min read
View all news articles
Flat-vector server rack expanding core cluster on a slate-ice gradient background signaling AMD stock data-center momentum ahead of earnings.

KEY TAKEAWAYS

  • Q4 data-center revenue reached $5.4 billion, a company record driven by EPYC and MI300 sales.
  • Q4 total revenue was $10.3 billion, topping the $9.7 billion estimate.
  • Bernstein raised its 12-month target, and analyst consensus showed a $290 median price target.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Advanced Micro Devices Inc. (AMD) shares rose on April 16, 2026, after Bernstein raised its 12-month price target, pushing the stock toward record levels ahead of the company’s Q1 2026 earnings report on May 5.

Data-Center Growth and Financial Results

AMD’s data-center revenue reached $5.4 billion in the fourth quarter of 2025, a 39% increase year-over-year and a company record, driven by sales of EPYC server processors and MI300 AI accelerators. Total revenue for the quarter was $10.3 billion, up 34% from a year earlier and above the $9.7 billion estimate.

For the full year 2025, AMD reported revenue of $34.6 billion, a 34% increase from 2024. Net income rose to $4.3 billion from $1.6 billion the prior year.

Management said the company entered 2026 with strong momentum led by EPYC and Ryzen processors and rapid growth in its data-center AI business. Consensus models project earnings per share rising from $6.64 in 2026 to $14.45 in 2028, with revenue potentially reaching about $85 billion.

Industry forecasts support this outlook. Gartner projects global semiconductor revenue will exceed $1.3 trillion in 2026, with AI-focused chips accounting for roughly 30% of the market.

Analyst Targets and Strategic Catalysts

Bernstein raised its 12-month price target on AMD, citing stronger server assumptions and the impact of a Meta AI deal. Analyst coverage remains positive, with 37 buy or strong-buy ratings, 12 holds, and no sell recommendations. The median price target is $290, with an average near $289.

EPYC server sales are a key growth driver. One analyst projects these sales could rise about 50% year-over-year in 2026.

AMD has expanded a multi-year collaboration with France on national AI initiatives, including work related to the Alice Recoque exascale supercomputer. The company also participated in a $60 million Series D financing round for U.K. autonomous-vehicle startup Wayve, alongside Arm and Qualcomm, reinforcing its AI positioning.

Some recent downgrades have raised concerns about valuation, execution risks, GPU competitiveness, and hyperscalers’ moves toward custom silicon.

Investors will focus on AMD’s Q1 results on May 5 to assess whether the data-center and AI momentum continues into 2026.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Netflix Earnings Send NFLX Stock Lower

Netflix Earnings Send NFLX Stock Lower

Netflix earnings for Q1 2026 beat forecasts but weak Q2 guidance and Reed Hastings' planned June exit pushed shares lower in after-hours trading.

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos limited Glasswing rollout to banks prompted regulator scrutiny and raised cyber and operational risk, complicating bank positioning.

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines liquidation risk rises as jet fuel may exceed year-end cash, prompting creditors' doubts and forcing traders to reassess credit exposure.

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 went general; pricing stayed unchanged and Mythos stayed gated, a setup that could shift cloud AI costs and investor positioning.

Abbott Earnings Beat After Exact Sciences Deal

Abbott Earnings Beat After Exact Sciences Deal

Abbott earnings posted revenue and adjusted-profit beats but narrowed FY EPS guidance after the Exact Sciences acquisition, likely pressuring shares.

Hims & Hers Stock Climbs on Peptide Policy Shift

Hims & Hers Stock Climbs on Peptide Policy Shift

Hims & Hers stock rose after praising FDA steps to reassess peptide restrictions, driving trader interest ahead of the July advisory committee review.